Journal
/
Cancer Research
/
Standardizing Ovarian Cancer Organoid Biobanking
/
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Standardizing Ovarian Cancer Organoid Biobanking

DOI:
10.3791/66467-v

•

02:12 min

•

February 23, 2024

•

, , , , , ,
1Department of Obstetrics and Gynecology,University Hospital, Ludwig-Maximilian-University (LMU) Munich, 2German Cancer Consortium (DKTK), Partner site Munich (LMU), a partnership between the German Cancer Research Center (DKFZ) and the University Hospital of LMU Munich

Tags

Keywords: Ovarian CancerOrganoidsBiobankingPatient-derivedHeterogeneityHistological SubtypesDisease StagesTranslational ResearchIndividualized ManagementPredictive BiomarkersMultivisceral SurgeryChemotherapyAnti-angiogenic TherapyPARP InhibitorHomologous Recombination DeficiencyBiologic ModelsChemotherapy ResponseTargeted TreatmentsCulture RequirementsRenewal Potential3D CultureStandardizationProgenitor CellsExperimental Workflow2D/3D Seeding

Embed

ADD TO PLAYLIST

Usage Statistics

Related Videos

check_url/66467?article_type=v

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

check_url/66467?article_type=v

Establishment of Ovarian Cancer Organoid Culture and its Evaluation
check_url/66467?article_type=v

Ovarian Cancer Organoid Passaging and Cryopreservation for Long-Term Organoid Cultivation
check_url/66467?article_type=v

Fixation of Ovarian Cancer Organoids for Long-Term Storage

Read Article